Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Brown, Gordon
LEGEND study, NCT04752722: LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve	Recruiting	1/2	222	Canada, US	EG-70 (phase 1), Phase 1, EG-70 (phase 2), Phase 2	enGene, Inc.	Superficial Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ	06/25	05/27
Sussman, David
TITAN 2, NCT05226286: Evaluation of Implantable Tibial Neuromodulation Pivotal Study	Active, not recruiting	N/A	188	US	Medtronic Implantable Tibial Neuromodulation (TNM) System	MedtronicNeuro	Overactive Bladder	10/23	04/25
Mauro, Kelly
NCT04232696: Neuspera's Implantable Sacral Nerve Stimulation System in Patients With Symptoms of Urinary Urgency Incontinence (UUI)	Active, not recruiting	N/A	242	Europe, US	Neuspera Implantable Sacral Nerve Stimulation System	Neuspera Medical, Inc.	Urinary Urgency Incontinence	07/24	12/26